Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

被引：0
|
作者：
Cindy L. J. Weinstein
Alan G. Meehan
Jianxin Lin
Steven D. Briscoe
Marinella Govoni
机构：
[1] Merck & Co.,
[2] Inc,undefined
[3] MSD Italy,undefined
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Golimumab; TNF-α; Treatment persistence; Rheumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3397 / 3405
页数：8
相关论文
共 50 条
  • [21] THE PERSISTENCE OF GOLIMUMAB IN DAILY CLINICAL PRACTICE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, AND PSORIATIC ARTHRITIS : ANALYSIS OF PROSPECTIVELY COLLECTED DATA IN THE SLOVENIAN NATIONAL ONLINE REGISTRY OF PATIENTS TREATED WITH BIOLOGICS
    Biorx, S., I
    Rotar, Z.
    Tomsic, M.
    VALUE IN HEALTH, 2016, 19 (03) : A228 - A228
  • [22] Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting
    Serrano-Benavente, Belen
    Valor, Larissa
    del Rio Blasco, Tamara
    Janta, Iustina
    Gonzalez Benitez, Roberto
    Nieto-Gonzalez, Juan Carlos
    Martinez-Barrio, Julia
    Ovalles Bonilla, Juan Gabriel
    Ariza, Alfonso
    Lopez-Longo, Francisco Javier
    Alvaro-Gracia, Jose Maria
    Monteagudo, Indalecio
    Gonzalez-Fernandez, Carlos Manuel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E150 - E155
  • [23] Improvement & Maintenance of Hemoglobin Levels Among Rheumatoid Arthritis, Psoriatic Arthritis&Ankylosing Spondylitis Patients with Anemia of Inflammation After Treatment with Golimumab:3 Year Pooled Analysis
    Furst, Daniel E.
    Gathany, Tim
    Kay, Jonathan
    Wasko, Mary Chester
    Keystone, Edward
    Kavanaugh, Arthur
    Deodhar, Atul
    Murphy, Frederick T.
    Han, Chenglong
    Doyle, Mittie K.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S487 - S487
  • [24] GOLIMUMAB 3-YEAR SAFETY UPDATE: AN ANALYSIS OF POOLED DATA FROM THE LONG TERM EXTENSIONS OF RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Kay, J.
    Fleischmann, R.
    Keystone, E.
    Hsia, E. C.
    Doyle, M. K.
    Hsu, B.
    Mack, M.
    Beutler, A.
    Braun, J.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 515 - 516
  • [25] Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
    Burmester, Gerd R.
    Panaccione, Remo
    Gordon, Kenneth B.
    McIlraith, Melissa J.
    Lacerda, Ana P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 517 - 524
  • [26] Golimumab 3-Year Safety Update: An Analysis of Pooled Data From the Long Term Extensions of Randomized, Double-Blind, Placebo-Controlled Studies in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Kay, Jonathan
    Fleischmann, Roy
    Keystone, Edward
    Hsia, Elizabeth C.
    Doyle, Mittie K.
    Hsu, Benjamin
    Mack, Michael
    Beutler, Anna
    Braun, Juergen
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S870 - S870
  • [27] Effect of Long-Term Treatment with Secukinumab on Cardio-Metabolic Profile in Patients with Active Ankylosing Spondylitis and Psoriatic Arthritis: Pooled 3 Year Analysis
    McInnes, Iain
    Gladman, Dafna
    Deodhar, Atul
    Miceli-Richard, Corinne
    Nash, Peter
    Sattar, Naveed
    Mehta, Nehal
    Asquith, Darren
    Wang, Jianyuan
    Richards, Hanno
    Pricop, Luminita
    Shete, Abhijit
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
    Manuel Pombo-Suarez
    Carlos Sanchez-Piedra
    Blanca Garcia-Magallón
    Ana Pérez-Gómez
    Sara Manrique-Arija
    Raquel Martín-Doménech
    María Colazo
    Cristina Campos
    José Campos
    Javier del Pino-Montes
    Maria J. Arteaga
    Luis Cea-Calvo
    Federico Díaz-González
    Juan J. Gómez-Reino
    Clinical Rheumatology, 2021, 40 : 3979 - 3988
  • [29] Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
    Pombo-Suarez, Manuel
    Sanchez-Piedra, Carlos
    Garcia-Magallon, Blanca
    Perez-Gomez, Ana
    Manrique-Arija, Sara
    Martin-Domenech, Raquel
    Colazo, Maria
    Campos, Cristina
    Campos, Jose
    del Pino-Montes, Javier
    Arteaga, Maria J.
    Cea-Calvo, Luis
    Diaz-Gonzalez, Federico
    Gomez-Reino, Juan J.
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 3979 - 3988
  • [30] Predictors of Long-Term Retention of Methotrexate and Other DMARDs with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry
    Haaland, Derek
    Jaroszynska, Anna
    Haraoui, Boulos
    Kapur, Suneil
    Stewart, Jaqueline
    Olszynski, Wojciech
    Anderson, Keltie
    Rai, Raman
    Starr, Michael
    Tsoukas, Alexender
    Psaradellis, Eliofotisti
    Rampakakis, Emmanouil
    Tkaczyk, Cathy
    Lehman, Allen
    Nantel, Francois
    Osborne, Brendan
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 978 - 978
12345